Skip to Main Content

Paper Details

Relapse-independent multiple sclerosis progression under natalizumab.
Brain Commun
12
2021
multiple sclerosis, natalizumab, patients, relapsing-remitting multiple sclerosis
Author NameAffiliation
Hans-Peter HartungUniversity Hospital, Heinrich-Heine-University
Hans-Peter HartungPalacky University in Olomouc
Hans-Peter HartungMedical University of Vienna
Hans-Peter HartungUniversity of Sydney
Joachim HavlaInstitute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University Munich
Joachim HavlaLMU Hospital, Ludwig-Maximilians University
  • 1 - 6

Datasets

Release 1.2